{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T03:22:03Z","timestamp":1789701723849,"version":"4.0.1"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T00:00:00Z","timestamp":1533859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s10555-018-9752-y","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T01:20:10Z","timestamp":1533864010000},"page":"355-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["The roles of the COX2\/PGE2\/EP axis in therapeutic resistance"],"prefix":"10.1007","volume":"37","author":[{"given":"Dali","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin-ang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiubo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luofu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianzheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,10]]},"reference":[{"issue":"1","key":"9752_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21387","volume":"67","author":"RL Siegel","year":"2017","unstructured":"Siegel, R. L., Miller, K. D., & Jemal, A. (2017). Cancer statistics, 2017. CA: a Cancer Journal for Clinicians, 67(1), 7\u201330. https:\/\/doi.org\/10.3322\/caac.21387 .","journal-title":"CA: a Cancer Journal for Clinicians"},{"issue":"1","key":"9752_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jtcvs.2012.09.030","volume":"145","author":"F Lou","year":"2013","unstructured":"Lou, F., Huang, J., Sima, C. S., Dycoco, J., Rusch, V., & Bach, P. B. (2013). Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. The Journal of Thoracic and Cardiovascular Surgery, 145(1), 75\u201381; discussion 81-72. https:\/\/doi.org\/10.1016\/j.jtcvs.2012.09.030 .","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"7203","key":"9752_CR3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008). Cancer-related inflammation. Nature, 454(7203), 436\u2013444. https:\/\/doi.org\/10.1038\/nature07205 .","journal-title":"Nature"},{"issue":"6","key":"9752_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1001\/jama.2009.1112","volume":"302","author":"AT Chan","year":"2009","unstructured":"Chan, A. T., Ogino, S., & Fuchs, C. S. (2009). Aspirin use and survival after diagnosis of colorectal cancer. JAMA, 302(6), 649\u2013658. https:\/\/doi.org\/10.1001\/jama.2009.1112 .","journal-title":"JAMA"},{"issue":"1","key":"9752_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.canlet.2010.03.015","volume":"295","author":"WK Wu","year":"2010","unstructured":"Wu, W. K., Sung, J. J., Lee, C. W., Yu, J., & Cho, C. H. (2010). Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Letters, 295(1), 7\u201316. https:\/\/doi.org\/10.1016\/j.canlet.2010.03.015 .","journal-title":"Cancer Letters"},{"issue":"3","key":"9752_CR6","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang, D., & Dubois, R. N. (2010). Eicosanoids and cancer. Nature Reviews. Cancer, 10(3), 181\u2013193. https:\/\/doi.org\/10.1038\/nrc2809 .","journal-title":"Nature Reviews. Cancer"},{"issue":"1\u20134","key":"9752_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.prostaglandins.2011.08.005","volume":"96","author":"EP Chen","year":"2011","unstructured":"Chen, E. P., & Smyth, E. M. (2011). COX-2 and PGE2-dependent immunomodulation in breast cancer. Prostaglandins & Other Lipid Mediators, 96(1\u20134), 14\u201320. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.08.005 .","journal-title":"Prostaglandins & Other Lipid Mediators"},{"key":"9752_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.bbrep.2017.06.006","volume":"11","author":"B Steinecker-Frohnwieser","year":"2017","unstructured":"Steinecker-Frohnwieser, B., Kaltenegger, H., Weigl, L., Mann, A., Kullich, W., Leithner, A., & Lohberger, B. (2017). Pharmacological treatment with diacerein combined with mechanical stimulation affects the expression of growth factors in human chondrocytes. Biochemistry and Biophysics Reports, 11, 154\u2013160. https:\/\/doi.org\/10.1016\/j.bbrep.2017.06.006 .","journal-title":"Biochemistry and Biophysics Reports"},{"issue":"1","key":"9752_CR9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12929-018-0419-3","volume":"25","author":"YJ Peng","year":"2018","unstructured":"Peng, Y. J., Shen, T. L., Chen, Y. S., Mersmann, H. J., Liu, B. H., & Ding, S. T. (2018). Adiponectin and adiponectin receptor 1 overexpression enhance inflammatory bowel disease. Journal of Biomedical Science, 25(1), 24. https:\/\/doi.org\/10.1186\/s12929-018-0419-3 .","journal-title":"Journal of Biomedical Science"},{"issue":"1","key":"9752_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10549-011-1521-3","volume":"132","author":"HS Kim","year":"2012","unstructured":"Kim, H. S., Moon, H. G., Han, W., Yom, C. K., Kim, W. H., Kim, J. H., & Noh, D. Y. (2012). COX2 overexpression is a prognostic marker for stage III breast cancer. Breast Cancer Research and Treatment, 132(1), 51\u201359. https:\/\/doi.org\/10.1007\/s10549-011-1521-3 .","journal-title":"Breast Cancer Research and Treatment"},{"key":"9752_CR11","unstructured":"(2005). PGE2 produced by lung cancer suppresses immune function through T-regulatory cells and can be blocked by the COX2 inhibitor celebrex. Cancer Biology & Therapy, 4(8), v\u2013vi."},{"issue":"5","key":"9752_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1111\/j.1365-2184.2007.00459.x","volume":"40","author":"N Banu","year":"2007","unstructured":"Banu, N., Buda, A., Chell, S., Elder, D., Moorghen, M., Paraskeva, C., Qualtrough, D., & Pignatelli, M. (2007). Inhibition of COX-2 with NS-398 decreases colon cancer cell motility through blocking epidermal growth factor receptor transactivation: possibilities for combination therapy. Cell Proliferation, 40(5), 768\u2013779. https:\/\/doi.org\/10.1111\/j.1365-2184.2007.00459.x .","journal-title":"Cell Proliferation"},{"issue":"10","key":"9752_CR13","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/neuonc\/now049","volume":"18","author":"PJ Cook","year":"2016","unstructured":"Cook, P. J., Thomas, R., Kingsley, P. J., Shimizu, F., Montrose, D. C., Marnett, L. J., Tabar, V. S., Dannenberg, A. J., & Benezra, R. (2016). Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma. Neuro-Oncology, 18(10), 1379\u20131389. https:\/\/doi.org\/10.1093\/neuonc\/now049 .","journal-title":"Neuro-Oncology"},{"key":"9752_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2016.12.031","volume":"389","author":"D Tong","year":"2017","unstructured":"Tong, D., Liu, Q., Liu, G., Xu, J., Lan, W., Jiang, Y., Xiao, H., Zhang, D., & Jiang, J. (2017). Metformin inhibits castration-induced EMT in prostate cancer by repressing COX2\/PGE2\/STAT3 axis. Cancer Letters, 389, 23\u201332. https:\/\/doi.org\/10.1016\/j.canlet.2016.12.031 .","journal-title":"Cancer Letters"},{"issue":"19","key":"9752_CR15","doi-asserted-by":"publisher","first-page":"28235","DOI":"10.18632\/oncotarget.8595","volume":"7","author":"Q Liu","year":"2016","unstructured":"Liu, Q., Yuan, W., Tong, D., Liu, G., Lan, W., Zhang, D., et al. (2016). Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2\/PGE2\/STAT3 axis. Oncotarget, 7(19), 28235\u201328246. https:\/\/doi.org\/10.18632\/oncotarget.8595 .","journal-title":"Oncotarget"},{"issue":"32","key":"9752_CR16","doi-asserted-by":"publisher","first-page":"4597","DOI":"10.1038\/onc.2017.82","volume":"36","author":"CJ Ko","year":"2017","unstructured":"Ko, C. J., Lan, S. W., Lu, Y. C., Cheng, T. S., Lai, P. F., Tsai, C. H., Hsu, T. W., Lin, H. Y., Shyu, H. Y., Wu, S. R., Lin, H. H., Hsiao, P. W., Chen, C. H., Huang, H. P., & Lee, M. S. (2017). Inhibition of cyclooxygenase-2-mediated matriptase activation contributes to the suppression of prostate cancer cell motility and metastasis. Oncogene, 36(32), 4597\u20134609. https:\/\/doi.org\/10.1038\/onc.2017.82 .","journal-title":"Oncogene"},{"key":"9752_CR17","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/1471-2407-8-237","volume":"8","author":"RE Harris","year":"2008","unstructured":"Harris, R. E., Beebe-Donk, J., & Alshafie, G. A. (2008). Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer, 8, 237. https:\/\/doi.org\/10.1186\/1471-2407-8-237 .","journal-title":"BMC Cancer"},{"key":"9752_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3727\/096504018X15148192843443","volume":"26","author":"H Jia","year":"2018","unstructured":"Jia, H., Wang, H., Yao, Y., Wang, C., & Li, P. (2018). MiR-136 inhibits malignant progression of hepatocellular carcinoma cells by targeting cyclooxygenase 2. Oncology Research, 26, 967\u2013976. https:\/\/doi.org\/10.3727\/096504018X15148192843443 .","journal-title":"Oncology Research"},{"issue":"2","key":"9752_CR19","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/cas.13462","volume":"109","author":"G Teng","year":"2018","unstructured":"Teng, G., Dai, Y., Chu, Y., Li, J., Zhang, H., Wu, T., Shuai, X., & Wang, W. (2018). Helicobacter pylori induces caudal-type homeobox protein 2 and cyclooxygenase 2 expression by modulating microRNAs in esophageal epithelial cells. Cancer Science, 109(2), 297\u2013307. https:\/\/doi.org\/10.1111\/cas.13462 .","journal-title":"Cancer Science"},{"key":"9752_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40659-016-0071-x","volume":"49","author":"JF Codocedo","year":"2016","unstructured":"Codocedo, J. F., & Inestrosa, N. C. (2016). Wnt-5a-regulated miR-101b controls COX2 expression in hippocampal neurons. Biological Research, 49, 9. https:\/\/doi.org\/10.1186\/s40659-016-0071-x .","journal-title":"Biological Research"},{"issue":"24 Pt B","key":"9752_CR21","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1016\/j.febslet.2015.11.001","volume":"589","author":"E Hu","year":"2015","unstructured":"Hu, E., Ding, L., Miao, H., Liu, F., Liu, D., Dou, H., et al. (2015). MiR-30a attenuates immunosuppressive functions of IL-1beta-elicited mesenchymal stem cells via targeting TAB3. FEBS Letters, 589(24 Pt B), 3899\u20133907. https:\/\/doi.org\/10.1016\/j.febslet.2015.11.001 .","journal-title":"FEBS Letters"},{"issue":"2","key":"9752_CR22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3892\/ijo.2012.1743","volume":"42","author":"Y Lai","year":"2013","unstructured":"Lai, Y., Zhang, X., Zhang, Z., Shu, Y., Luo, X., Yang, Y., et al. (2013). The microRNA-27a: ZBTB10-specificity protein pathway is involved in follicle stimulating hormone-induced VEGF, Cox2 and survivin expression in ovarian epithelial cancer cells. International Journal of Oncology, 42(2), 776\u2013784. https:\/\/doi.org\/10.3892\/ijo.2012.1743 .","journal-title":"International Journal of Oncology"},{"issue":"1","key":"9752_CR23","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1186\/s12885-016-2716-0","volume":"16","author":"Q He","year":"2016","unstructured":"He, Q., Chen, Z., Dong, Q., Zhang, L., Chen, D., Patel, A., Koya, A., Luan, X., Cabay, R. J., Dai, Y., Wang, A., & Zhou, X. (2016). MicroRNA-21 regulates prostaglandin E2 signaling pathway by targeting 15-hydroxyprostaglandin dehydrogenase in tongue squamous cell carcinoma. BMC Cancer, 16(1), 685. https:\/\/doi.org\/10.1186\/s12885-016-2716-0 .","journal-title":"BMC Cancer"},{"issue":"2","key":"9752_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.7150\/thno.22059","volume":"8","author":"YH Lai","year":"2018","unstructured":"Lai, Y. H., Liu, H., Chiang, W. F., Chen, T. W., Chu, L. J., Yu, J. S., Chen, S. J., Chen, H. C., & Tan, B. C. M. (2018). MiR-31-5p-ACOX1 axis enhances tumorigenic fitness in oral squamous cell carcinoma via the promigratory prostaglandin E2. Theranostics, 8(2), 486\u2013504. https:\/\/doi.org\/10.7150\/thno.22059 .","journal-title":"Theranostics"},{"issue":"21","key":"9752_CR25","doi-asserted-by":"publisher","first-page":"35033","DOI":"10.18632\/oncotarget.16591","volume":"8","author":"LM Mehdawi","year":"2017","unstructured":"Mehdawi, L. M., Satapathy, S. R., Gustafsson, A., Lundholm, K., Alvarado-Kristensson, M., & Sjolander, A. (2017). A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells. Oncotarget, 8(21), 35033\u201335047. https:\/\/doi.org\/10.18632\/oncotarget.16591 .","journal-title":"Oncotarget"},{"key":"9752_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.abb.2016.04.011","volume":"603","author":"H Akasaka","year":"2016","unstructured":"Akasaka, H., & Ruan, K. H. (2016). Identification of the two-phase mechanism of arachidonic acid regulating inflammatory prostaglandin E2 biosynthesis by targeting COX-2 and mPGES-1. Archives of Biochemistry and Biophysics, 603, 29\u201337. https:\/\/doi.org\/10.1016\/j.abb.2016.04.011 .","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"5","key":"9752_CR27","doi-asserted-by":"publisher","first-page":"5519","DOI":"10.3892\/ol.2017.6843","volume":"14","author":"J Zhao","year":"2017","unstructured":"Zhao, J., Wen, S., Wang, X., & Zhang, Z. (2017). Helicobacter pylori modulates cyclooxygenase-2 and 15-hydroxy prostaglandin dehydrogenase in gastric cancer. Oncology Letters, 14(5), 5519\u20135525. https:\/\/doi.org\/10.3892\/ol.2017.6843 .","journal-title":"Oncology Letters"},{"issue":"1","key":"9752_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3892\/ol.2016.5448","volume":"13","author":"AG Asting","year":"2017","unstructured":"Asting, A. G., Iresjo, B. M., Nilsberth, C., Smedh, U., & Lundholm, K. (2017). Host knockout of E-prostanoid 2 receptors reduces tumor growth and causes major alterations of gene expression in prostaglandin E2-producing tumors. Oncology Letters, 13(1), 476\u2013482. https:\/\/doi.org\/10.3892\/ol.2016.5448 .","journal-title":"Oncology Letters"},{"issue":"2","key":"9752_CR29","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3892\/or.2015.4043","volume":"34","author":"M Du","year":"2015","unstructured":"Du, M., Shi, F., Zhang, H., Xia, S., Zhang, M., Ma, J., et al. (2015). Prostaglandin E2 promotes human cholangiocarcinoma cell proliferation, migration and invasion through the upregulation of beta-catenin expression via EP3-4 receptor. Oncology Reports, 34(2), 715\u2013726. https:\/\/doi.org\/10.3892\/or.2015.4043 .","journal-title":"Oncology Reports"},{"issue":"19","key":"9752_CR30","doi-asserted-by":"publisher","first-page":"31270","DOI":"10.18632\/oncotarget.16116","volume":"8","author":"L Bazzani","year":"2017","unstructured":"Bazzani, L., Donnini, S., Finetti, F., Christofori, G., & Ziche, M. (2017). PGE2\/EP3\/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells. Oncotarget, 8(19), 31270\u201331287. https:\/\/doi.org\/10.18632\/oncotarget.16116 .","journal-title":"Oncotarget"},{"issue":"4","key":"9752_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jamcollsurg.2017.07.521","volume":"225","author":"MT Yip-Schneider","year":"2017","unstructured":"Yip-Schneider, M. T., Carr, R. A., Wu, H., & Schmidt, C. M. (2017). Prostaglandin E2: a pancreatic fluid biomarker of intraductal papillary mucinous neoplasm dysplasia. Journal of the American College of Surgeons, 225(4), 481\u2013487. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2017.07.521 .","journal-title":"Journal of the American College of Surgeons"},{"issue":"3","key":"9752_CR32","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1158\/1055-9965.EPI-16-0556","volume":"26","author":"S Kim","year":"2017","unstructured":"Kim, S., Campbell, J., Yoo, W., Taylor, J. A., & Sandler, D. P. (2017). Systemic levels of estrogens and PGE2 synthesis in relation to postmenopausal breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention, 26(3), 383\u2013388. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0556 .","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"16","key":"9752_CR33","doi-asserted-by":"publisher","first-page":"9244","DOI":"10.1073\/pnas.1033060100","volume":"100","author":"G Reid","year":"2003","unstructured":"Reid, G., Wielinga, P., Zelcer, N., van der Heijden, I., Kuil, A., de Haas, M., Wijnholds, J., & Borst, P. (2003). The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proceedings of the National Academy of Sciences of the United States of America, 100(16), 9244\u20139249. https:\/\/doi.org\/10.1073\/pnas.1033060100 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"9752_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.prostaglandins.2014.11.003","volume":"116-117","author":"TJ Kochel","year":"2015","unstructured":"Kochel, T. J., & Fulton, A. M. (2015). Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. Prostaglandins & Other Lipid Mediators, 116-117, 99\u2013103. https:\/\/doi.org\/10.1016\/j.prostaglandins.2014.11.003 .","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"4","key":"9752_CR35","doi-asserted-by":"publisher","first-page":"6540","DOI":"10.18632\/oncotarget.14145","volume":"8","author":"TJ Kochel","year":"2017","unstructured":"Kochel, T. J., Reader, J. C., Ma, X., Kundu, N., & Fulton, A. M. (2017). Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal\/triple negative breast cancer. Oncotarget, 8(4), 6540\u20136554. https:\/\/doi.org\/10.18632\/oncotarget.14145 .","journal-title":"Oncotarget"},{"key":"9752_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.4137\/BCBCR.S38529","volume":"10","author":"TJ Kochel","year":"2016","unstructured":"Kochel, T. J., Goloubeva, O. G., & Fulton, A. M. (2016). Upregulation of cyclooxygenase-2\/prostaglandin E2 (COX-2\/PGE2) pathway member multiple drug resistance-associated protein 4 (MRP4) and downregulation of prostaglandin transporter (PGT) and 15-prostaglandin dehydrogenase (15-PGDH) in triple-negative breast cancer. Breast Cancer (Auckl.), 10, 61\u201370. https:\/\/doi.org\/10.4137\/BCBCR.S38529 .","journal-title":"Breast Cancer (Auckl.)"},{"issue":"16","key":"9752_CR37","doi-asserted-by":"publisher","first-page":"11613","DOI":"10.1074\/jbc.R600038200","volume":"282","author":"Y Sugimoto","year":"2007","unstructured":"Sugimoto, Y., & Narumiya, S. (2007). Prostaglandin E receptors. The Journal of Biological Chemistry, 282(16), 11613\u201311617. https:\/\/doi.org\/10.1074\/jbc.R600038200 .","journal-title":"The Journal of Biological Chemistry"},{"issue":"4","key":"9752_CR38","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1002\/jcp.26220","volume":"233","author":"A Madrigal-Martinez","year":"2018","unstructured":"Madrigal-Martinez, A., Fernandez-Martinez, A. B., & Lucio Cazana, F. J. (2018). Intracrine prostaglandin E2 pro-tumoral actions in prostate epithelial cells originate from non-canonical pathways. Journal of Cellular Physiology, 233(4), 3590\u20133602. https:\/\/doi.org\/10.1002\/jcp.26220 .","journal-title":"Journal of Cellular Physiology"},{"issue":"2","key":"9752_CR39","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1002\/mc.22524","volume":"56","author":"S Lian","year":"2017","unstructured":"Lian, S., Xia, Y., Ung, T. T., Khoi, P. N., Yoon, H. J., Lee, S. G., Kim, K. K., & Jung, Y. D. (2017). Prostaglandin E2 stimulates urokinase-type plasminogen activator receptor via EP2 receptor-dependent signaling pathways in human AGS gastric cancer cells. Molecular Carcinogenesis, 56(2), 664\u2013680. https:\/\/doi.org\/10.1002\/mc.22524 .","journal-title":"Molecular Carcinogenesis"},{"key":"9752_CR40","doi-asserted-by":"publisher","first-page":"33823","DOI":"10.1038\/srep33823","volume":"6","author":"J Pan","year":"2016","unstructured":"Pan, J., Yang, Q., Shao, J., Zhang, L., Ma, J., Wang, Y., Jiang, B. H., Leng, J., & Bai, X. (2016). Cyclooxygenase-2 induced beta1-integrin expression in NSCLC and promoted cell invasion via the EP1\/MAPK\/E2F-1\/FoxC2 signal pathway. Scientific Reports, 6, 33823. https:\/\/doi.org\/10.1038\/srep33823 .","journal-title":"Scientific Reports"},{"issue":"6","key":"9752_CR41","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.surg.2016.12.037","volume":"161","author":"A Schmidt","year":"2017","unstructured":"Schmidt, A., Sinnett-Smith, J., Young, S., Chang, H. H., Hines, O. J., Dawson, D. W., Rozengurt, E., & Eibl, G. (2017). Direct growth-inhibitory effects of prostaglandin E2 in pancreatic cancer cells in vitro through an EP4\/PKA-mediated mechanism. Surgery, 161(6), 1570\u20131578. https:\/\/doi.org\/10.1016\/j.surg.2016.12.037 .","journal-title":"Surgery"},{"issue":"17","key":"9752_CR42","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1007\/s00018-015-1891-5","volume":"72","author":"AB Fernandez-Martinez","year":"2015","unstructured":"Fernandez-Martinez, A. B., & Lucio-Cazana, J. (2015). Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells. Cellular and Molecular Life Sciences, 72(17), 3355\u20133373. https:\/\/doi.org\/10.1007\/s00018-015-1891-5 .","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"5753","key":"9752_CR43","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1126\/science.1116221","volume":"310","author":"MD Castellone","year":"2005","unstructured":"Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005). Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science, 310(5753), 1504\u20131510. https:\/\/doi.org\/10.1126\/science.1116221 .","journal-title":"Science"},{"issue":"3","key":"9752_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/nm0302-289","volume":"8","author":"R Pai","year":"2002","unstructured":"Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002). Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy. Nature Medicine, 8(3), 289\u2013293. https:\/\/doi.org\/10.1038\/nm0302-289 .","journal-title":"Nature Medicine"},{"issue":"5","key":"9752_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1006\/bbrc.2001.5494","volume":"286","author":"R Pai","year":"2001","unstructured":"Pai, R., Szabo, I. L., Soreghan, B. A., Atay, S., Kawanaka, H., & Tarnawski, A. S. (2001). PGE(2) stimulates VEGF expression in endothelial cells via ERK2\/JNK1 signaling pathways. Biochemical and Biophysical Research Communications, 286(5), 923\u2013928. https:\/\/doi.org\/10.1006\/bbrc.2001.5494 .","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"9752_CR46","doi-asserted-by":"publisher","first-page":"2048731","DOI":"10.1155\/2016\/2048731","volume":"2016","author":"LY Pang","year":"2016","unstructured":"Pang, L. Y., Hurst, E. A., & Argyle, D. J. (2016). Cyclooxygenase-2: a role in cancer stem cell survival and repopulation of cancer cells during therapy. Stem Cells International, 2016, 2048731\u20132048711. https:\/\/doi.org\/10.1155\/2016\/2048731 .","journal-title":"Stem Cells International"},{"issue":"2","key":"9752_CR47","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.trsl.2013.03.004","volume":"162","author":"AG Paul","year":"2013","unstructured":"Paul, A. G., Chandran, B., & Sharma-Walia, N. (2013). Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi\u2019s sarcoma-associated herpes virus associated malignancies. Translational Research, 162(2), 77\u201392. https:\/\/doi.org\/10.1016\/j.trsl.2013.03.004 .","journal-title":"Translational Research"},{"issue":"1","key":"9752_CR48","doi-asserted-by":"publisher","first-page":"e84941","DOI":"10.1371\/journal.pone.0084941","volume":"9","author":"J Liao","year":"2014","unstructured":"Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W. J., Lele, S. B., Morrison, C. D., & Odunsi, K. (2014). Ovarian cancer spheroid cells with stem cell-like properties contribute to tumor generation, metastasis and chemotherapy resistance through hypoxia-resistant metabolism. PLoS One, 9(1), e84941. https:\/\/doi.org\/10.1371\/journal.pone.0084941 .","journal-title":"PLoS One"},{"issue":"18","key":"9752_CR49","first-page":"5821","volume":"63","author":"SK Singh","year":"2003","unstructured":"Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., & Dirks, P. B. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63(18), 5821\u20135828.","journal-title":"Cancer Research"},{"issue":"7","key":"9752_CR50","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nm.2385","volume":"17","author":"Q Huang","year":"2011","unstructured":"Huang, Q., Li, F., Liu, X., Li, W., Shi, W., Liu, F. F., O'Sullivan, B., He, Z., Peng, Y., Tan, A. C., Zhou, L., Shen, J., Han, G., Wang, X. J., Thorburn, J., Thorburn, A., Jimeno, A., Raben, D., Bedford, J. S., & Li, C. Y. (2011). Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nature Medicine, 17(7), 860\u2013866. https:\/\/doi.org\/10.1038\/nm.2385 .","journal-title":"Nature Medicine"},{"issue":"7","key":"9752_CR51","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2174\/1871520615666150318100822","volume":"15","author":"GK Chimal-Ramirez","year":"2015","unstructured":"Chimal-Ramirez, G. K., Espinoza-Sanchez, N. A., & Fuentes-Panana, E. M. (2015). A role for the inflammatory mediators cox-2 and metalloproteinases in cancer stemness. Anti-Cancer Agents in Medicinal Chemistry, 15(7), 837\u2013855.","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"1","key":"9752_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10549-013-2779-4","volume":"143","author":"N Kundu","year":"2014","unstructured":"Kundu, N., Ma, X., Kochel, T., Goloubeva, O., Staats, P., Thompson, K., Martin, S., Reader, J., Take, Y., Collin, P., & Fulton, A. (2014). Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties. Breast Cancer Research and Treatment, 143(1), 19\u201331. https:\/\/doi.org\/10.1007\/s10549-013-2779-4 .","journal-title":"Breast Cancer Research and Treatment"},{"issue":"8","key":"9752_CR53","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/anie.201510443","volume":"55","author":"JN Boodram","year":"2016","unstructured":"Boodram, J. N., McGregor, I. J., Bruno, P. M., Cressey, P. B., Hemann, M. T., & Suntharalingam, K. (2016). Breast cancer stem cell potent copper(II)-non-steroidal anti-inflammatory drug complexes. Angewandte Chemie (International Ed. in English), 55(8), 2845\u20132850. https:\/\/doi.org\/10.1002\/anie.201510443 .","journal-title":"Angewandte Chemie (International Ed. in English)"},{"issue":"7","key":"9752_CR54","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1053\/j.gastro.2015.07.064","volume":"149","author":"D Wang","year":"2015","unstructured":"Wang, D., Fu, L., Sun, H., Guo, L., & DuBois, R. N. (2015). Prostaglandin E2 promotes colorectal cancer stem cell expansion and metastasis in mice. Gastroenterology, 149(7), 1884\u20131895 e1884. https:\/\/doi.org\/10.1053\/j.gastro.2015.07.064 .","journal-title":"Gastroenterology"},{"issue":"2","key":"9752_CR55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3109\/07357907.2012.754458","volume":"31","author":"Y Deng","year":"2013","unstructured":"Deng, Y., Su, Q., Mo, J., Fu, X., Zhang, Y., & Lin, E. H. (2013). Celecoxib downregulates CD133 expression through inhibition of the Wnt signaling pathway in colon cancer cells. Cancer Investigation, 31(2), 97\u2013102. https:\/\/doi.org\/10.3109\/07357907.2012.754458 .","journal-title":"Cancer Investigation"},{"issue":"44","key":"9752_CR56","doi-asserted-by":"publisher","first-page":"e1806","DOI":"10.1097\/MD.0000000000001806","volume":"94","author":"Z Guo","year":"2015","unstructured":"Guo, Z., Jiang, J. H., Zhang, J., Yang, H. J., Yang, F. Q., Qi, Y. P., Zhong, Y. P., Su, J., Yang, R. R., Li, L. Q., & Xiang, B. D. (2015). COX-2 promotes migration and invasion by the side population of cancer stem cell-like hepatocellular carcinoma cells. Medicine (Baltimore), 94(44), e1806. https:\/\/doi.org\/10.1097\/MD.0000000000001806 .","journal-title":"Medicine (Baltimore)"},{"key":"9752_CR57","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s12917-014-0184-9","volume":"10","author":"LY Pang","year":"2014","unstructured":"Pang, L. Y., Argyle, S. A., Kamida, A., Morrison, K. O., & Argyle, D. J. (2014). The long-acting COX-2 inhibitor mavacoxib (Trocoxil) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. BMC Veterinary Research, 10, 184. https:\/\/doi.org\/10.1186\/s12917-014-0184-9 .","journal-title":"BMC Veterinary Research"},{"key":"9752_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1742-2094-8-32","volume":"8","author":"M Tafani","year":"2011","unstructured":"Tafani, M., Di Vito, M., Frati, A., Pellegrini, L., De Santis, E., Sette, G., et al. (2011). Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. Journal of Neuroinflammation, 8, 32. https:\/\/doi.org\/10.1186\/1742-2094-8-32 .","journal-title":"Journal of Neuroinflammation"},{"issue":"7533","key":"9752_CR59","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/nature14034","volume":"517","author":"AV Kurtova","year":"2015","unstructured":"Kurtova, A. V., Xiao, J., Mo, Q., Pazhanisamy, S., Krasnow, R., Lerner, S. P., Chen, F., Roh, T. T., Lay, E., Ho, P. L., & Chan, K. S. (2015). Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance. Nature, 517(7533), 209\u2013213. https:\/\/doi.org\/10.1038\/nature14034 .","journal-title":"Nature"},{"issue":"16","key":"9752_CR60","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1158\/0008-5472.CAN-16-2990","volume":"77","author":"PC Hou","year":"2017","unstructured":"Hou, P. C., Li, Y. H., Lin, S. C., Lee, J. C., Lin, B. W., Liou, J. P., et al. (2017). Hypoxia-induced downregulation of DUSP-2 phosphatase drives colon cancer stemness. Cancer Research, 77(16), 4305\u20134316. https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-2990 .","journal-title":"Cancer Research"},{"issue":"1","key":"9752_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/iju.13404","volume":"25","author":"D Fang","year":"2018","unstructured":"Fang, D., & Kitamura, H. (2018). Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: possible pathways and potential therapeutic approaches. International Journal of Urology, 25(1), 7\u201317. https:\/\/doi.org\/10.1111\/iju.13404 .","journal-title":"International Journal of Urology"},{"issue":"47","key":"9752_CR62","doi-asserted-by":"publisher","first-page":"82217","DOI":"10.18632\/oncotarget.19283","volume":"8","author":"M Wu","year":"2017","unstructured":"Wu, M., Guan, J., Li, C., Gunter, S., Nusrat, L., Ng, S., et al. (2017). Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma. Oncotarget, 8(47), 82217\u201382230. https:\/\/doi.org\/10.18632\/oncotarget.19283 .","journal-title":"Oncotarget"},{"issue":"5","key":"9752_CR63","doi-asserted-by":"publisher","first-page":"e0123478","DOI":"10.1371\/journal.pone.0123478","volume":"10","author":"X Liu","year":"2015","unstructured":"Liu, X., Ji, Q., Ye, N., Sui, H., Zhou, L., Zhu, H., Fan, Z., Cai, J., & Li, Q. (2015). Berberine inhibits invasion and metastasis of colorectal cancer cells via COX-2\/PGE2 mediated JAK2\/STAT3 signaling pathway. PLoS One, 10(5), e0123478. https:\/\/doi.org\/10.1371\/journal.pone.0123478 .","journal-title":"PLoS One"},{"issue":"1","key":"9752_CR64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000147748","volume":"154","author":"ED Hay","year":"1995","unstructured":"Hay, E. D. (1995). An overview of epithelio-mesenchymal transformation. Acta Anatomica (Basel), 154(1), 8\u201320.","journal-title":"Acta Anatomica (Basel)"},{"issue":"6","key":"9752_CR65","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri, R., & Weinberg, R. A. (2009). The basics of epithelial-mesenchymal transition. The Journal of Clinical Investigation, 119(6), 1420\u20131428. https:\/\/doi.org\/10.1172\/JCI39104 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"6","key":"9752_CR66","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.ceb.2003.10.006","volume":"15","author":"JP Thiery","year":"2003","unstructured":"Thiery, J. P. (2003). Epithelial-mesenchymal transitions in development and pathologies. Current Opinion in Cell Biology, 15(6), 740\u2013746.","journal-title":"Current Opinion in Cell Biology"},{"issue":"11","key":"9752_CR67","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.neo.2014.09.004","volume":"16","author":"EG Mathenge","year":"2014","unstructured":"Mathenge, E. G., Dean, C. A., Clements, D., Vaghar-Kashani, A., Photopoulos, S., Coyle, K. M., Giacomantonio, M., Malueth, B., Nunokawa, A., Jordan, J., Lewis, J. D., Gujar, S. A., Marcato, P., Lee, P. W. K., & Giacomantonio, C. A. (2014). Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model. Neoplasia, 16(11), 950\u2013960. https:\/\/doi.org\/10.1016\/j.neo.2014.09.004 .","journal-title":"Neoplasia"},{"issue":"11","key":"9752_CR68","doi-asserted-by":"publisher","first-page":"e26100","DOI":"10.1371\/journal.pone.0026100","volume":"6","author":"CA Aktipis","year":"2011","unstructured":"Aktipis, C. A., Kwan, V. S., Johnson, K. A., Neuberg, S. L., & Maley, C. C. (2011). Overlooking evolution: a systematic analysis of cancer relapse and therapeutic resistance research. PLoS One, 6(11), e26100. https:\/\/doi.org\/10.1371\/journal.pone.0026100 .","journal-title":"PLoS One"},{"key":"9752_CR69","doi-asserted-by":"publisher","unstructured":"Du, B., & Shim, J. S. (2016). Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules, 21(7). https:\/\/doi.org\/10.3390\/molecules21070965 .","DOI":"10.3390\/molecules21070965"},{"issue":"344","key":"9752_CR70","doi-asserted-by":"publisher","first-page":"re8","DOI":"10.1126\/scisignal.2005189","volume":"7","author":"DM Gonzalez","year":"2014","unstructured":"Gonzalez, D. M., & Medici, D. (2014). Signaling mechanisms of the epithelial-mesenchymal transition. Science Signaling, 7(344), re8. https:\/\/doi.org\/10.1126\/scisignal.2005189 .","journal-title":"Science Signaling"},{"issue":"Suppl 3","key":"9752_CR71","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1002\/lary.24998","volume":"125","author":"MA St John","year":"2015","unstructured":"St John, M. A. (2015). Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma. Laryngoscope, 125(Suppl 3), S1\u2013S11. https:\/\/doi.org\/10.1002\/lary.24998 .","journal-title":"Laryngoscope"},{"issue":"2","key":"9752_CR72","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1517\/14728222.2014.860447","volume":"18","author":"C Bocca","year":"2014","unstructured":"Bocca, C., Ievolella, M., Autelli, R., Motta, M., Mosso, L., Torchio, B., Bozzo, F., Cannito, S., Paternostro, C., Colombatto, S., Parola, M., & Miglietta, A. (2014). Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness. Expert Opinion on Therapeutic Targets, 18(2), 121\u2013135. https:\/\/doi.org\/10.1517\/14728222.2014.860447 .","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"9752_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1756-9966-33-40","volume":"33","author":"R Fujii","year":"2014","unstructured":"Fujii, R., Imanishi, Y., Shibata, K., Sakai, N., Sakamoto, K., Shigetomi, S., Habu, N., Otsuka, K., Sato, Y., Watanabe, Y., Ozawa, H., Tomita, T., Kameyama, K., Fujii, M., & Ogawa, K. (2014). Restoration of E-cadherin expression by selective Cox-2 inhibition and the clinical relevance of the epithelial-to-mesenchymal transition in head and neck squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research, 33, 40. https:\/\/doi.org\/10.1186\/1756-9966-33-40 .","journal-title":"Journal of Experimental & Clinical Cancer Research"},{"issue":"37","key":"9752_CR74","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.3748\/wjg.v19.i37.6265","volume":"19","author":"XJ Liu","year":"2013","unstructured":"Liu, X. J., Chen, Z. F., Li, H. L., Hu, Z. N., Liu, M., Tian, A. P., Zhao, D., Wu, J., Zhou, Y. N., & Qiao, L. (2013). Interaction between cyclooxygenase-2, Snail, and E-cadherin in gastric cancer cells. World Journal of Gastroenterology, 19(37), 6265\u20136271. https:\/\/doi.org\/10.3748\/wjg.v19.i37.6265 .","journal-title":"World Journal of Gastroenterology"},{"issue":"2\u20133","key":"9752_CR75","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cbi.2009.08.006","volume":"182","author":"F Bozzo","year":"2009","unstructured":"Bozzo, F., Bassignana, A., Lazzarato, L., Boschi, D., Gasco, A., Bocca, C., & Miglietta, A. (2009). Novel nitro-oxy derivatives of celecoxib for the regulation of colon cancer cell growth. Chemico-Biological Interactions, 182(2\u20133), 183\u2013190. https:\/\/doi.org\/10.1016\/j.cbi.2009.08.006 .","journal-title":"Chemico-Biological Interactions"},{"issue":"6","key":"9752_CR76","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.1002\/jcp.26323","volume":"233","author":"S Dinicola","year":"2018","unstructured":"Dinicola, S., Masiello, M. G., Proietti, S., Coluccia, P., Fabrizi, G., Catizone, A., Ricci, G., de Toma, G., Bizzarri, M., & Cucina, A. (2018). Nicotine increases colon cancer cell migration and invasion through epithelial to mesenchymal transition (EMT): COX-2 involvement. Journal of Cellular Physiology, 233(6), 4935\u20134948. https:\/\/doi.org\/10.1002\/jcp.26323 .","journal-title":"Journal of Cellular Physiology"},{"issue":"1","key":"9752_CR77","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/jcmm.12418","volume":"19","author":"SR Jansen","year":"2015","unstructured":"Jansen, S. R., Holman, R., Hedemann, I., Frankes, E., Elzinga, C. R., Timens, W., et al. (2015). Prostaglandin E2 promotes MYCN non-amplified neuroblastoma cell survival via beta-catenin stabilization. Journal of Cellular and Molecular Medicine, 19(1), 210\u2013226. https:\/\/doi.org\/10.1111\/jcmm.12418 .","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"9752_CR78","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molimm.2017.06.018","volume":"90","author":"D Che","year":"2017","unstructured":"Che, D., Zhang, S., Jing, Z., Shang, L., Jin, S., Liu, F., Shen, J., Li, Y., Hu, J., Meng, Q., & Yu, Y. (2017). Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2\/PGE2\/beta-catenin signalling pathway. Molecular Immunology, 90, 197\u2013210. https:\/\/doi.org\/10.1016\/j.molimm.2017.06.018 .","journal-title":"Molecular Immunology"},{"issue":"29","key":"9752_CR79","doi-asserted-by":"publisher","first-page":"46354","DOI":"10.18632\/oncotarget.10128","volume":"7","author":"SR Jansen","year":"2016","unstructured":"Jansen, S. R., Poppinga, W. J., de Jager, W., Lezoualc'h, F., Cheng, X., Wieland, T., et al. (2016). Epac1 links prostaglandin E2 to beta-catenin-dependent transcription during epithelial-to-mesenchymal transition. Oncotarget, 7(29), 46354\u201346370. https:\/\/doi.org\/10.18632\/oncotarget.10128 .","journal-title":"Oncotarget"},{"issue":"1","key":"9752_CR80","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41598-017-18612-3","volume":"8","author":"M Majumder","year":"2018","unstructured":"Majumder, M., Dunn, L., Liu, L., Hasan, A., Vincent, K., Brackstone, M., Hess, D., & Lala, P. K. (2018). COX-2 induces oncogenic micro RNA miR655 in human breast cancer. Scientific Reports, 8(1), 327. https:\/\/doi.org\/10.1038\/s41598-017-18612-3 .","journal-title":"Scientific Reports"},{"issue":"5","key":"9752_CR81","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/cr.2015.51","volume":"25","author":"P Li","year":"2015","unstructured":"Li, P., Shan, J. X., Chen, X. H., Zhang, D., Su, L. P., Huang, X. Y., Yu, B. Q., Zhi, Q. M., Li, C. L., Wang, Y. Q., Tomei, S., Cai, Q., Ji, J., Li, J. F., Chouchane, L., Yu, Y. Y., Sun, F. Z., Xu, Z. H., Liu, B. Y., & Zhu, Z. G. (2015). Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2\/interleukin-6 signaling in the tumor microenvironment. Cell Research, 25(5), 588\u2013603. https:\/\/doi.org\/10.1038\/cr.2015.51 .","journal-title":"Cell Research"},{"issue":"12","key":"9752_CR82","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.bcp.2010.06.039","volume":"80","author":"A Deorukhkar","year":"2010","unstructured":"Deorukhkar, A., & Krishnan, S. (2010). Targeting inflammatory pathways for tumor radiosensitization. Biochemical Pharmacology, 80(12), 1904\u20131914. https:\/\/doi.org\/10.1016\/j.bcp.2010.06.039 .","journal-title":"Biochemical Pharmacology"},{"issue":"3","key":"9752_CR83","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.bbrc.2017.06.117","volume":"490","author":"AM Jimenez-Garduno","year":"2017","unstructured":"Jimenez-Garduno, A. M., Mendoza-Rodriguez, M. G., Urrutia-Cabrera, D., Dominguez-Robles, M. C., Perez-Yepez, E. A., Ayala-Sumuano, J. T., et al. (2017). IL-1beta induced methylation of the estrogen receptor ERalpha gene correlates with EMT and chemoresistance in breast cancer cells. Biochemical and Biophysical Research Communications, 490(3), 780\u2013785. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.117 .","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"8","key":"9752_CR84","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1172\/JCI93182","volume":"127","author":"K Jung","year":"2017","unstructured":"Jung, K., Heishi, T., Khan, O. F., Kowalski, P. S., Incio, J., Rahbari, N. N., Chung, E., Clark, J. W., Willett, C. G., Luster, A. D., Yun, S. H., Langer, R., Anderson, D. G., Padera, T. P., Jain, R. K., & Fukumura, D. (2017). Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy. The Journal of Clinical Investigation, 127(8), 3039\u20133051. https:\/\/doi.org\/10.1172\/JCI93182 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"2","key":"9752_CR85","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3892\/ol.2017.6305","volume":"14","author":"K Gonda","year":"2017","unstructured":"Gonda, K., Shibata, M., Ohtake, T., Matsumoto, Y., Tachibana, K., Abe, N., Ohto, H., Sakurai, K., & Takenoshita, S. (2017). Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer. Oncology Letters, 14(2), 1766\u20131774. https:\/\/doi.org\/10.3892\/ol.2017.6305 .","journal-title":"Oncology Letters"},{"key":"9752_CR86","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12935-015-0260-7","volume":"15","author":"B Liu","year":"2015","unstructured":"Liu, B., Qu, L., & Yan, S. (2015). Cyclooxygenase-2 promotes tumor growth and suppresses tumor immunity. Cancer Cell International, 15, 106. https:\/\/doi.org\/10.1186\/s12935-015-0260-7 .","journal-title":"Cancer Cell International"},{"issue":"6","key":"9752_CR87","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.cell.2015.08.015","volume":"162","author":"S Zelenay","year":"2015","unstructured":"Zelenay, S., van der Veen, A. G., Bottcher, J. P., Snelgrove, K. J., Rogers, N., Acton, S. E., et al. (2015). Cyclooxygenase-dependent tumor growth through evasion of immunity. Cell, 162(6), 1257\u20131270. https:\/\/doi.org\/10.1016\/j.cell.2015.08.015 .","journal-title":"Cell"},{"issue":"5","key":"9752_CR88","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","volume":"172","author":"JP Bottcher","year":"2018","unstructured":"Bottcher, J. P., Bonavita, E., Chakravarty, P., Blees, H., Cabeza-Cabrerizo, M., Sammicheli, S., et al. (2018). NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control. Cell, 172(5), 1022\u20131037 e1014. https:\/\/doi.org\/10.1016\/j.cell.2018.01.004 .","journal-title":"Cell"},{"issue":"2","key":"9752_CR89","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ccell.2016.06.003","volume":"30","author":"EW Roberts","year":"2016","unstructured":"Roberts, E. W., Broz, M. L., Binnewies, M., Headley, M. B., Nelson, A. E., Wolf, D. M., Kaisho, T., Bogunovic, D., Bhardwaj, N., & Krummel, M. F. (2016). Critical role for CD103(+)\/CD141(+) dendritic cells bearing CCR7 for tumor antigen trafficking and priming of T cell immunity in melanoma. Cancer Cell, 30(2), 324\u2013336. https:\/\/doi.org\/10.1016\/j.ccell.2016.06.003 .","journal-title":"Cancer Cell"},{"issue":"4","key":"9752_CR90","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2016.03.012","volume":"44","author":"H Salmon","year":"2016","unstructured":"Salmon, H., Idoyaga, J., Rahman, A., Leboeuf, M., Remark, R., Jordan, S., Casanova-Acebes, M., Khudoynazarova, M., Agudo, J., Tung, N., Chakarov, S., Rivera, C., Hogstad, B., Bosenberg, M., Hashimoto, D., Gnjatic, S., Bhardwaj, N., Palucka, A. K., Brown, B. D., Brody, J., Ginhoux, F., & Merad, M. (2016). Expansion and activation of CD103(+) dendritic cell progenitors at the tumor site enhances tumor responses to therapeutic PD-L1 and BRAF inhibition. Immunity, 44(4), 924\u2013938. https:\/\/doi.org\/10.1016\/j.immuni.2016.03.012 .","journal-title":"Immunity"},{"issue":"5","key":"9752_CR91","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","volume":"31","author":"S Spranger","year":"2017","unstructured":"Spranger, S., Dai, D., Horton, B., & Gajewski, T. F. (2017). Tumor-residing Batf3 dendritic cells are required for effector T cell trafficking and adoptive T cell therapy. Cancer Cell, 31(5), 711\u2013723 e714. https:\/\/doi.org\/10.1016\/j.ccell.2017.04.003 .","journal-title":"Cancer Cell"},{"issue":"6","key":"9752_CR92","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ccell.2014.11.010","volume":"26","author":"ML Broz","year":"2014","unstructured":"Broz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., Amigorena, S., van\u2019t Veer, L. J., Sperling, A. I., Wolf, D. M., & Krummel, M. F. (2014). Dissecting the tumor myeloid compartment reveals rare activating antigen-presenting cells critical for T cell immunity. Cancer Cell, 26(6), 938. https:\/\/doi.org\/10.1016\/j.ccell.2014.11.010 .","journal-title":"Cancer Cell"},{"issue":"5","key":"9752_CR93","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.ccell.2014.09.006","volume":"26","author":"B Ruffell","year":"2014","unstructured":"Ruffell, B., Chang-Strachan, D., Chan, V., Rosenbusch, A., Ho, C. M., Pryer, N., et al. (2014). Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells. Cancer Cell, 26(5), 623\u2013637. https:\/\/doi.org\/10.1016\/j.ccell.2014.09.006 .","journal-title":"Cancer Cell"},{"issue":"9","key":"9752_CR94","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1158\/0008-5472.CAN-06-4174","volume":"67","author":"P Sinha","year":"2007","unstructured":"Sinha, P., Clements, V. K., Fulton, A. M., & Ostrand-Rosenberg, S. (2007). Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Research, 67(9), 4507\u20134513. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-4174 .","journal-title":"Cancer Research"},{"issue":"3\u20134","key":"9752_CR95","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1007\/s10555-007-9096-5","volume":"26","author":"MT Wang","year":"2007","unstructured":"Wang, M. T., Honn, K. V., & Nie, D. (2007). Cyclooxygenases, prostanoids, and tumor progression. Cancer Metastasis Reviews, 26(3\u20134), 525\u2013534. https:\/\/doi.org\/10.1007\/s10555-007-9096-5 .","journal-title":"Cancer Metastasis Reviews"},{"issue":"6","key":"9752_CR96","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/icb.2011.75","volume":"90","author":"V Sreeramkumar","year":"2012","unstructured":"Sreeramkumar, V., Fresno, M., & Cuesta, N. (2012). Prostaglandin E2 and T cells: friends or foes? Immunology and Cell Biology, 90(6), 579\u2013586. https:\/\/doi.org\/10.1038\/icb.2011.75 .","journal-title":"Immunology and Cell Biology"},{"issue":"7","key":"9752_CR97","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1080\/01635581.2017.1359320","volume":"69","author":"GC Galvan","year":"2017","unstructured":"Galvan, G. C., Johnson, C. B., Price, R. S., Liss, M. A., Jolly, C. A., & deGraffenried, L. A. (2017). Effects of obesity on the regulation of macrophage population in the prostate tumor microenvironment. Nutrition and Cancer, 69(7), 996\u20131002. https:\/\/doi.org\/10.1080\/01635581.2017.1359320 .","journal-title":"Nutrition and Cancer"},{"issue":"5","key":"9752_CR98","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1073\/pnas.1612920114","volume":"114","author":"V Prima","year":"2017","unstructured":"Prima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017). COX2\/mPGES1\/PGE2 pathway regulates PD-L1 expression in tumor-associated macrophages and myeloid-derived suppressor cells. Proceedings of the National Academy of Sciences of the United States of America, 114(5), 1117\u20131122. https:\/\/doi.org\/10.1073\/pnas.1612920114 .","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"9752_CR99","doi-asserted-by":"publisher","first-page":"10284","DOI":"10.18632\/oncotarget.3581","volume":"6","author":"C Olesch","year":"2015","unstructured":"Olesch, C., Sha, W., Angioni, C., Sha, L. K., Acaf, E., Patrignani, P., et al. (2015). MPGES-1-derived PGE2 suppresses CD80 expression on tumor-associated phagocytes to inhibit anti-tumor immune responses in breast cancer. Oncotarget, 6(12), 10284\u201310296. https:\/\/doi.org\/10.18632\/oncotarget.3581 .","journal-title":"Oncotarget"},{"issue":"12","key":"9752_CR100","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/carcin\/bgx104","volume":"38","author":"H Furuya","year":"2017","unstructured":"Furuya, H., Tamashiro, P. M., Shimizu, Y., Iino, K., Peres, R., Chen, R., Sun, Y., Hannun, Y. A., Obeid, L. M., & Kawamori, T. (2017). Sphingosine kinase 1 expression in peritoneal macrophages is required for colon carcinogenesis. Carcinogenesis, 38(12), 1218\u20131227. https:\/\/doi.org\/10.1093\/carcin\/bgx104 .","journal-title":"Carcinogenesis"},{"issue":"12","key":"9752_CR101","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.150.12.5321","volume":"150","author":"FG Snijdewint","year":"1993","unstructured":"Snijdewint, F. G., Kalinski, P., Wierenga, E. A., Bos, J. D., & Kapsenberg, M. L. (1993). Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. Journal of Immunology, 150(12), 5321\u20135329.","journal-title":"Journal of Immunology"},{"issue":"6","key":"9752_CR102","first-page":"1208","volume":"58","author":"M Huang","year":"1998","unstructured":"Huang, M., Stolina, M., Sharma, S., Mao, J. T., Zhu, L., Miller, P. W., Wollman, J., Herschman, H., & Dubinett, S. M. (1998). Non-small cell lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin 10 and down-regulation of interleukin 12 production. Cancer Research, 58(6), 1208\u20131216.","journal-title":"Cancer Research"},{"issue":"7","key":"9752_CR103","doi-asserted-by":"publisher","first-page":"e1016700","DOI":"10.1080\/2162402X.2015.1016700","volume":"4","author":"AA Wu","year":"2015","unstructured":"Wu, A. A., Drake, V., Huang, H. S., Chiu, S., & Zheng, L. (2015). Reprogramming the tumor microenvironment: tumor-induced immunosuppressive factors paralyze T cells. Oncoimmunology, 4(7), e1016700. https:\/\/doi.org\/10.1080\/2162402X.2015.1016700 .","journal-title":"Oncoimmunology"},{"issue":"1","key":"9752_CR104","doi-asserted-by":"publisher","first-page":"361","DOI":"10.4049\/jimmunol.164.1.361","volume":"164","author":"M Stolina","year":"2000","unstructured":"Stolina, M., Sharma, S., Lin, Y., Dohadwala, M., Gardner, B., Luo, J., Zhu, L., Kronenberg, M., Miller, P. W., Portanova, J., Lee, J. C., & Dubinett, S. M. (2000). Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. Journal of Immunology, 164(1), 361\u2013370.","journal-title":"Journal of Immunology"},{"issue":"52","key":"9752_CR105","doi-asserted-by":"publisher","first-page":"89802","DOI":"10.18632\/oncotarget.21155","volume":"8","author":"J Miao","year":"2017","unstructured":"Miao, J., Lu, X., Hu, Y., Piao, C., Wu, X., Liu, X., et al. (2017). Prostaglandin E2 and PD-1 mediated inhibition of antitumor CTL responses in the human tumor microenvironment. Oncotarget, 8(52), 89802\u201389810. https:\/\/doi.org\/10.18632\/oncotarget.21155 .","journal-title":"Oncotarget"},{"issue":"Suppl 2","key":"9752_CR106","doi-asserted-by":"publisher","first-page":"V74","DOI":"10.1359\/jbmr.07s213","volume":"22","author":"AV Krishnan","year":"2007","unstructured":"Krishnan, A. V., Moreno, J., Nonn, L., Swami, S., Peehl, D. M., & Feldman, D. (2007). Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. Journal of Bone and Mineral Research, 22(Suppl 2), V74\u2013V80. https:\/\/doi.org\/10.1359\/jbmr.07s213 .","journal-title":"Journal of Bone and Mineral Research"},{"issue":"7","key":"9752_CR107","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3748\/wjg.v23.i7.1171","volume":"23","author":"HH Hsu","year":"2017","unstructured":"Hsu, H. H., Chen, M. C., Day, C. H., Lin, Y. M., Li, S. Y., Tu, C. C., Padma, V. V., Shih, H. N., Kuo, W. W., & Huang, C. Y. (2017). Thymoquinone suppresses migration of LoVo human colon cancer cells by reducing prostaglandin E2 induced COX-2 activation. World Journal of Gastroenterology, 23(7), 1171\u20131179. https:\/\/doi.org\/10.3748\/wjg.v23.i7.1171 .","journal-title":"World Journal of Gastroenterology"},{"issue":"10","key":"9752_CR108","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.2174\/1871520617666170327153735","volume":"17","author":"MM Ghorab","year":"2017","unstructured":"Ghorab, M. M., El-Gaby, M. S. A., Alsaid, M. S., Elshaier, Y., Soliman, A. M., El-Senduny, F. F., et al. (2017). Novel thiourea derivatives bearing sulfonamide moiety as anticancer agents through COX-2 inhibition. Anti-Cancer Agents in Medicinal Chemistry, 17(10), 1411\u20131425. https:\/\/doi.org\/10.2174\/1871520617666170327153735 .","journal-title":"Anti-Cancer Agents in Medicinal Chemistry"},{"issue":"39","key":"9752_CR109","doi-asserted-by":"publisher","first-page":"41794","DOI":"10.18632\/oncotarget.5993","volume":"6","author":"G Qin","year":"2015","unstructured":"Qin, G., Xu, F., Qin, T., Zheng, Q., Shi, D., Xia, W., et al. (2015). Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun\/COX-2 signaling pathway. Oncotarget, 6(39), 41794\u201341808. https:\/\/doi.org\/10.18632\/oncotarget.5993 .","journal-title":"Oncotarget"},{"issue":"1","key":"9752_CR110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4143\/crt.2016.190","volume":"49","author":"IH Pun","year":"2017","unstructured":"Pun, I. H., Chan, D., Chan, S. H., Chung, P. Y., Zhou, Y. Y., Law, S., et al. (2017). Anti-cancer effects of a novel quinoline derivative 83b1 on human esophageal squamous cell carcinoma through down-regulation of COX-2 mRNA and PGE2. Cancer Research and Treatment, 49(1), 219\u2013229. https:\/\/doi.org\/10.4143\/crt.2016.190 .","journal-title":"Cancer Research and Treatment"},{"issue":"1","key":"9752_CR111","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10787-017-0310-y","volume":"25","author":"A Verma","year":"2017","unstructured":"Verma, A., Ahmed, B., Anwar, F., Rahman, M., Patel, D. K., Kaithwas, G., Rani, R., Bhatt, P. C., & Kumar, V. (2017). Novel glycoside from Wedelia calendulacea inhibits diethyl nitrosamine-induced renal cancer via downregulating the COX-2 and PEG2 through nuclear factor-kappaB pathway. Inflammopharmacology, 25(1), 159\u2013175. https:\/\/doi.org\/10.1007\/s10787-017-0310-y .","journal-title":"Inflammopharmacology"},{"issue":"12","key":"9752_CR112","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1002\/tox.22204","volume":"31","author":"YM Lin","year":"2016","unstructured":"Lin, Y. M., Kuo, W. W., Velmurugan, B. K., Hsien, H. H., Hsieh, Y. L., Hsu, H. H., Tu, C. C., Bau, D. T., Viswanadha, V. P., & Huang, C. Y. (2016). Helioxanthin suppresses the cross talk of COX-2\/PGE2 and EGFR\/ERK pathway to inhibit arecoline-induced oral cancer cell (T28) proliferation and blocks tumor growth in xenografted nude mice. Environmental Toxicology, 31(12), 2045\u20132056. https:\/\/doi.org\/10.1002\/tox.22204 .","journal-title":"Environmental Toxicology"},{"issue":"10","key":"9752_CR113","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1248\/bpb.b17-00458","volume":"40","author":"N Seira","year":"2017","unstructured":"Seira, N., Yanagisawa, N., Suganami, A., Honda, T., Wasai, M., Regan, J. W., Fukushima, K., Yamaguchi, N., Tamura, Y., Arai, T., Murayama, T., & Fujino, H. (2017). Anti-cancer effects of MW-03, a novel indole compound, by inducing 15-hydroxyprostaglandin dehydrogenase and cellular growth inhibition in the LS174T human colon cancer cell line. Biological & Pharmaceutical Bulletin, 40(10), 1806\u20131812. https:\/\/doi.org\/10.1248\/bpb.b17-00458 .","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"6","key":"9752_CR114","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1172\/JCI69672","volume":"124","author":"SH Choi","year":"2014","unstructured":"Choi, S. H., Kim, B. G., Robinson, J., Fink, S., Yan, M., Sporn, M. B., Markowitz, S. D., & Letterio, J. J. (2014). Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis. The Journal of Clinical Investigation, 124(6), 2472\u20132482. https:\/\/doi.org\/10.1172\/JCI69672 .","journal-title":"The Journal of Clinical Investigation"},{"issue":"7","key":"9752_CR115","doi-asserted-by":"publisher","first-page":"7667","DOI":"10.18632\/oncotarget.6765","volume":"7","author":"N Kangwan","year":"2016","unstructured":"Kangwan, N., Kim, Y. J., Han, Y. M., Jeong, M., Park, J. M., Go, E. J., et al. (2016). Sonic Hedgehog inhibitors prevent colitis-associated cancer via orchestrated mechanisms of IL-6\/gp130 inhibition, 15-PGDH induction, Bcl-2 abrogation, and tumorsphere inhibition. Oncotarget, 7(7), 7667\u20137682. https:\/\/doi.org\/10.18632\/oncotarget.6765 .","journal-title":"Oncotarget"},{"issue":"1\u20134","key":"9752_CR116","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.prostaglandins.2011.06.005","volume":"96","author":"HH Tai","year":"2011","unstructured":"Tai, H. H., Chi, X., & Tong, M. (2011). Regulation of 15-hydroxyprostaglandin dehydrogenase (15-PGDH) by non-steroidal anti-inflammatory drugs (NSAIDs). Prostaglandins & Other Lipid Mediators, 96(1\u20134), 37\u201340. https:\/\/doi.org\/10.1016\/j.prostaglandins.2011.06.005 .","journal-title":"Prostaglandins & Other Lipid Mediators"},{"issue":"2","key":"9752_CR117","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2009.05.017","volume":"487","author":"X Chi","year":"2009","unstructured":"Chi, X., Freeman, B. M., Tong, M., Zhao, Y., & Tai, H. H. (2009). 15-Hydroxyprostaglandin dehydrogenase (15-PGDH) is up-regulated by flurbiprofen and other non-steroidal anti-inflammatory drugs in human colon cancer HT29 cells. Archives of Biochemistry and Biophysics, 487(2), 139\u2013145. https:\/\/doi.org\/10.1016\/j.abb.2009.05.017 .","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"14","key":"9752_CR118","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1016\/j.yexcr.2010.06.001","volume":"316","author":"X Chi","year":"2010","unstructured":"Chi, X., & Tai, H. H. (2010). Interleukin-4 up-regulates 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in human lung cancer cells. Experimental Cell Research, 316(14), 2251\u20132259.","journal-title":"Experimental Cell Research"},{"issue":"Pt 2","key":"9752_CR119","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1042\/bj2790553","volume":"279","author":"CQ Xun","year":"1991","unstructured":"Xun, C. Q., Tian, Z. G., & Tai, H. H. (1991). Stimulation of synthesis de novo of NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase in human promyelocytic leukaemia (HL-60) cells by phorbol ester. The Biochemical Journal, 279(Pt 2), 553\u2013558.","journal-title":"The Biochemical Journal"},{"issue":"7","key":"9752_CR120","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/j.1349-7006.2003.tb01492.x","volume":"94","author":"T Kitamura","year":"2003","unstructured":"Kitamura, T., Itoh, M., Noda, T., Tani, K., Kobayashi, M., Maruyama, T., Kobayashi, K., Ohuchida, S., Sugimura, T., & Wakabayashi, K. (2003). Combined effects of prostaglandin E receptor subtype EP1 and subtype EP4 antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. Cancer Science, 94(7), 618\u2013621.","journal-title":"Cancer Science"},{"issue":"4","key":"9752_CR121","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/ijc.20012","volume":"109","author":"T Kitamura","year":"2004","unstructured":"Kitamura, T., Itoh, M., Noda, T., Matsuura, M., & Wakabayashi, K. (2004). Combined effects of cyclooxygenase-1 and cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice. International Journal of Cancer, 109(4), 576\u2013580. https:\/\/doi.org\/10.1002\/ijc.20012 .","journal-title":"International Journal of Cancer"},{"issue":"5","key":"9752_CR122","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1349-7006.2005.00047.x","volume":"96","author":"N Niho","year":"2005","unstructured":"Niho, N., Mutoh, M., Kitamura, T., Takahashi, M., Sato, H., Yamamoto, H., Maruyama, T., Ohuchida, S., Sugimura, T., & Wakabayashi, K. (2005). Suppression of azoxymethane-induced colon cancer development in rats by a prostaglandin E receptor EP1-selective antagonist. Cancer Science, 96(5), 260\u2013264. https:\/\/doi.org\/10.1111\/j.1349-7006.2005.00047.x .","journal-title":"Cancer Science"},{"issue":"5","key":"9752_CR123","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/aps.2012.13","volume":"33","author":"J Jin","year":"2012","unstructured":"Jin, J., Chang, Y., Wei, W., He, Y. F., Hu, S. S., Wang, D., & Wu, Y. J. (2012). Prostanoid EP1 receptor as the target of (\u2212)-epigallocatechin-3-gallate in suppressing hepatocellular carcinoma cells in vitro. Acta Pharmacologica Sinica, 33(5), 701\u2013709. https:\/\/doi.org\/10.1038\/aps.2012.13 .","journal-title":"Acta Pharmacologica Sinica"},{"issue":"11","key":"9752_CR124","first-page":"3389","volume":"5","author":"IW Cheuk","year":"2015","unstructured":"Cheuk, I. W., Shin, V. Y., Siu, M. T., Tsang, J. Y., Ho, J. C., Chen, J., Tse, G. M., Wang, X., & Kwong, A. (2015). Association of EP2 receptor and SLC19A3 in regulating breast cancer metastasis. American Journal of Cancer Research, 5(11), 3389\u20133399.","journal-title":"American Journal of Cancer Research"},{"issue":"1\u20133","key":"9752_CR125","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2012.01.033","volume":"680","author":"Y Ikawa","year":"2012","unstructured":"Ikawa, Y., Fujino, H., Otake, S., & Murayama, T. (2012). Indomethacin antagonizes EP(2) prostanoid receptor activation in LS174T human colon cancer cells. European Journal of Pharmacology, 680(1\u20133), 16\u201321. https:\/\/doi.org\/10.1016\/j.ejphar.2012.01.033 .","journal-title":"European Journal of Pharmacology"},{"issue":"2","key":"9752_CR126","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/CJI.0b013e318247a5e9","volume":"35","author":"DM Holt","year":"2012","unstructured":"Holt, D. M., Ma, X., Kundu, N., Collin, P. D., & Fulton, A. M. (2012). Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. Journal of Immunotherapy, 35(2), 179\u2013188. https:\/\/doi.org\/10.1097\/CJI.0b013e318247a5e9 .","journal-title":"Journal of Immunotherapy"},{"issue":"10","key":"9752_CR127","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1158\/1541-7786.MCR-17-0077","volume":"15","author":"C Li","year":"2017","unstructured":"Li, C., Liu, X., Liu, Y., Zhang, E., Medepalli, K., Masuda, K., Li, N., Wikenheiser-Brokamp, K. A., Osterburg, A., Borchers, M. T., Kopras, E. J., Plas, D. R., Sun, J., Franz, D. N., Capal, J. K., Mays, M., Sun, Y., Kwiatkowski, D. J., Alayev, A., Holz, M. K., Krueger, D. A., Siroky, B. J., & Yu, J. J. (2017). Tuberin regulates prostaglandin receptor-mediated viability, via Rheb, in mTORC1-hyperactive cells. Molecular Cancer Research, 15(10), 1318\u20131330. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0077 .","journal-title":"Molecular Cancer Research"},{"issue":"6","key":"9752_CR128","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s10565-016-9351-z","volume":"32","author":"T Fang","year":"2016","unstructured":"Fang, T., Hou, J., He, M., Wang, L., Zheng, M., Wang, X., & Xia, J. (2016). Actinidia chinensis planch root extract (acRoots) inhibits hepatocellular carcinoma progression by inhibiting EP3 expression. Cell Biology and Toxicology, 32(6), 499\u2013511. https:\/\/doi.org\/10.1007\/s10565-016-9351-z .","journal-title":"Cell Biology and Toxicology"},{"issue":"1","key":"9752_CR129","doi-asserted-by":"publisher","first-page":"982","DOI":"10.18632\/oncotarget.23140","volume":"9","author":"J Zhu","year":"2018","unstructured":"Zhu, J., Trillsch, F., Mayr, D., Kuhn, C., Rahmeh, M., Hofmann, S., et al. (2018). Prostaglandin receptor EP3 regulates cell proliferation and migration with impact on survival of endometrial cancer patients. Oncotarget, 9(1), 982\u2013994. https:\/\/doi.org\/10.18632\/oncotarget.23140 .","journal-title":"Oncotarget"},{"issue":"3","key":"9752_CR130","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3892\/ijo_00000211","volume":"34","author":"H Hoshikawa","year":"2009","unstructured":"Hoshikawa, H., Goto, R., Mori, T., Mitani, T., & Mori, N. (2009). Expression of prostaglandin E2 receptors in oral squamous cell carcinomas and growth inhibitory effects of an EP3 selective antagonist, ONO-AE3-240. International Journal of Oncology, 34(3), 847\u2013852.","journal-title":"International Journal of Oncology"},{"issue":"1","key":"9752_CR131","doi-asserted-by":"publisher","first-page":"e22647","DOI":"10.4161\/onci.22647","volume":"2","author":"X Ma","year":"2013","unstructured":"Ma, X., Holt, D., Kundu, N., Reader, J., Goloubeva, O., Take, Y., & Fulton, A. M. (2013). A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis. Oncoimmunology, 2(1), e22647. https:\/\/doi.org\/10.4161\/onci.22647 .","journal-title":"Oncoimmunology"},{"issue":"4","key":"9752_CR132","first-page":"299","volume":"7","author":"FM Robertson","year":"2008","unstructured":"Robertson, F. M., Simeone, A. M., Mazumdar, A., Shah, A. H., McMurray, J. S., Ghosh, S., et al. (2008). Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells. Journal of Experimental Therapeutics & Oncology, 7(4), 299\u2013312.","journal-title":"Journal of Experimental Therapeutics & Oncology"},{"issue":"9","key":"9752_CR133","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1111\/cas.12475","volume":"105","author":"M Majumder","year":"2014","unstructured":"Majumder, M., Xin, X., Liu, L., Girish, G. V., & Lala, P. K. (2014). Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions. Cancer Science, 105(9), 1142\u20131151. https:\/\/doi.org\/10.1111\/cas.12475 .","journal-title":"Cancer Science"},{"issue":"6","key":"9752_CR134","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1080\/15384047.2015.1040953","volume":"16","author":"S Parida","year":"2015","unstructured":"Parida, S., Parekh, A., Dey, G., Ghosh, S. C., & Mandal, M. (2015). Molecular inhibition of prostaglandin E2 with GW627368X: therapeutic potential and preclinical safety assessment in mouse sarcoma model. Cancer Biology & Therapy, 16(6), 922\u2013932. https:\/\/doi.org\/10.1080\/15384047.2015.1040953 .","journal-title":"Cancer Biology & Therapy"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10555-018-9752-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-018-9752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-018-9752-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T07:57:08Z","timestamp":1693814228000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10555-018-9752-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,10]]},"references-count":134,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["9752"],"URL":"https:\/\/doi.org\/10.1007\/s10555-018-9752-y","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,10]]},"assertion":[{"value":"10 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}